Sara Elizabeth Tan Yap, MD | |
100 Fitness Dr, Bourbonnais, IL 60914-9584 | |
(815) 936-8909 | |
Not Available |
Full Name | Sara Elizabeth Tan Yap |
---|---|
Gender | Female |
Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
Location | 100 Fitness Dr, Bourbonnais, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225514334 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 036162611 (Illinois) | Primary |
207R00000X | Internal Medicine | 125.071666 (Illinois) | Secondary |
Entity Name | Riverside Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417061193 PECOS PAC ID: 3274434717 Enrollment ID: O20040116000780 |
News Archive
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Nymox Pharmaceutical Corporation outlined today the Company's development program for the Company's lead drug candidate, NX-1207, currently in Phase 3 trials in the U.S. for the treatment of benign prostatic hyperplasia (BPH). The drug has been successful in a series of blinded controlled multi-center U.S. clinical trials where it has been found to produce improvements that are about double that reported for currently approved BPH drugs.
Performing surgical operations without leaving scars has ceased to be a chimera and has become a reality. This is demonstrated by the recent surgical advances made using NOTES (Natural Orifice Transluminal Endoscopy Surgery), an innovative surgical approach that allows surgical access using the body's natural orifices.
People are much more likely to decide to donate a kidney to a stranger - an extraordinarily altruistic act - in areas of the United States where levels of well-being are high, according to a new study.
The Fiscal Times examines a recent report from the Agency for Healthcare Research and Quality about diabetes, "a disease that's costing Americans $83 billion a year in hospital fees—23 percent of total hospital spending. ... Add to this the costs of the hidden diabetes epidemic: $18 billion for the estimated 6.3 million people with undiagnosed diabetes, and $25 billion for 57 million, or one in four, American adults with pre-diabetes.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Sara Elizabeth Tan Yap, MD 100 Fitness Dr, Bourbonnais, IL 60914-9584 Ph: (815) 936-8909 | Sara Elizabeth Tan Yap, MD 100 Fitness Dr, Bourbonnais, IL 60914-9584 Ph: (815) 936-8909 |
News Archive
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Nymox Pharmaceutical Corporation outlined today the Company's development program for the Company's lead drug candidate, NX-1207, currently in Phase 3 trials in the U.S. for the treatment of benign prostatic hyperplasia (BPH). The drug has been successful in a series of blinded controlled multi-center U.S. clinical trials where it has been found to produce improvements that are about double that reported for currently approved BPH drugs.
Performing surgical operations without leaving scars has ceased to be a chimera and has become a reality. This is demonstrated by the recent surgical advances made using NOTES (Natural Orifice Transluminal Endoscopy Surgery), an innovative surgical approach that allows surgical access using the body's natural orifices.
People are much more likely to decide to donate a kidney to a stranger - an extraordinarily altruistic act - in areas of the United States where levels of well-being are high, according to a new study.
The Fiscal Times examines a recent report from the Agency for Healthcare Research and Quality about diabetes, "a disease that's costing Americans $83 billion a year in hospital fees—23 percent of total hospital spending. ... Add to this the costs of the hidden diabetes epidemic: $18 billion for the estimated 6.3 million people with undiagnosed diabetes, and $25 billion for 57 million, or one in four, American adults with pre-diabetes.
› Verified 5 days ago
Dr. Lynn A Mcdonald, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 482 Main St Nw, Bourbonnais, IL 60914 Phone: 815-936-3370 | |
Nadeem Ansari, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 400 Riverside Dr Ste 2100, Bourbonnais, IL 60914 Phone: 815-935-2784 Fax: 815-935-5687 | |
Dr. Dharam R Anand, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Provena Way Ste D, Bourbonnais, IL 60914 Phone: 815-932-9210 Fax: 815-932-9220 | |
Dr. Paritosh Tiwari, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 20 Heritage Dr, Bourbonnais, IL 60914 Phone: 815-937-4880 Fax: 815-936-5173 | |
Krupa Mahesh Shah, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1615 N Convent St Ste 1, Bourbonnais, IL 60914 Phone: 815-937-5200 Fax: 815-937-2063 | |
Dr. Sarat Yalamanchili, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1521 N Convent St Ste 101, Bourbonnais, IL 60914 Phone: 815-937-4500 Fax: 815-937-4777 |